Serial patent litigation refers to a branded pharmaceutical company suing a generic pharmaceutical company (i.e., a company that manufactures lower-cost versions of high-cost therapeutics) repeatedly regarding the same generic medication. This process delays the ability to bring generic medications to patients and, in some cases, may completely remove access. […]